コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 xchanger but opposite to localization of the vacuolar H-ATPase.
2 in receptor and is an essential component of vacuolar H+ ATPase.
3 e demonstrate a requirement for a functional vacuolar H+-ATPase.
4 of ATP were regulated by the activity of the vacuolar H+-ATPase.
5 Acidification of AVO was mediated by the vacuolar H+-ATPase.
6 s a peripheral membrane subunit of the yeast vacuolar H+-ATPase.
7 intenance of transmembrane pH gradients by a vacuolar H+-ATPase.
8 compound, or bafilomycin A1, an inhibitor of vacuolar H+-ATPase.
9 ut does lead to an increased activity of the vacuolar H(+)-ATPase.
10 ergic system, and work as a component of the vacuolar H(+) -ATPase.
11 oxin and a potent inhibitor of the mammalian vacuolar (H(+))-ATPase.
12 bstituted benzolactone enamides that inhibit vacuolar H(+) -ATPases.
13 its in hlh-30 mutant worms, and knockdown of vacuolar H+-ATPase 12 (vha-12) and its upstream regulato
18 CYAM accumulated slowly into puncta based on vacuolar H(+)-ATPase activity and dispersed rapidly upon
20 over, vacuoles from crd1Delta show decreased vacuolar H(+)-ATPase activity and proton pumping, which
21 gi network/early endosome (TGN/EE)-localized vacuolar H(+)-ATPase activity nor the function of the br
23 ization resulting from loss of Vma-dependent vacuolar H(+)-ATPase activity was not the cause of vma m
24 erevisiae and a Deltavma1 mutant, which lack vacuolar H(+)-ATPase activity, had large (fivefold or gr
25 esigned to identify novel genes required for vacuolar H+-ATPase activity in Saccharomyces cerevisiae.
30 nstituent proteins of the Ragulator complex (vacuolar (H(+))-ATPase and Lamtor1) require dynamic S-pa
33 tion was minimally affected by inhibition of vacuolar H(+)-ATPase and phosphatases but was markedly s
34 osin interacts with almost all components of vacuolar H(+)-ATPase and the Ragulator complex and with
35 th bafilomycin A1 (Baf), an inhibitor of the vacuolar H(+)-ATPase and therefore of endosomal-lysosoma
36 g permeabilized epimastigotes suggested that vacuolar H(+)-ATPase and V-H(+)-PPase activities are pre
39 age antimicrobial activity, and identify the vacuolar H(+)-ATPase as a potential target for host-dire
40 protein 115, transmembrane protein 199, and vacuolar H(+)-ATPase assembly integral membrane protein
41 r-specific HXK1 unconventional partners: the vacuolar H(+)-ATPase B1 (VHA-B1) and the 19S regulatory
42 dicate that recurrent stone formers with the vacuolar H(+)-ATPase B1 subunit p.E161K SNP exhibit a ur
46 and concanamycin A, a selective inhibitor of vacuolar H+ ATPases, demonstrating that these viruses re
47 bafilomycin A1, a specific inhibitor of the vacuolar H+-ATPase, did not alter the fusion protein mob
48 ical gradient (Deltamu(H+)) generated by the vacuolar H(+)-ATPase drives the accumulation of classica
49 ing mutants in transporters (pmr1, pdr5, and vacuolar H+-ATPase), ergosterol biosynthesis (erg3, erg6
50 cin A1 and concanamycin A, inhibitors of the vacuolar H(+)-ATPase, for its dependence on Rag GTPase i
51 nd shows weak homology to a component of the vacuolar H+-ATPase found in organisms as diverse as inse
52 al renal tubular acidosis (dRTA), absence of vacuolar H(+)-ATPase from collecting duct intercalated c
56 pump subunit (VPP-c, the 16-kDa subunit c of vacuolar H+-ATPase) has been identified as an interactin
58 erexpression on the stoichiometry within the vacuolar H(+)-ATPase heteromer and on neurological funct
59 ss requires (i) apical proton secretion by a vacuolar H(+)-ATPase, (ii) actin cytoskeleton reorganiza
61 in the membrane bound integral domain of the vacuolar H+-ATPase, in 27 patients with neurodevelopment
64 icroscopy, lysosomotropic agents such as the vacuolar H(+)-ATPase inhibitor bafilomycin A1 blocked th
65 locked by the NAADP antagonist Ned-19 or the vacuolar H(+)-ATPase inhibitor bafilomycin A1, indicatin
67 E-1 inhibitors (SM-19712, PD-069185) and the vacuolar H(+)ATPase inhibitor bafilomycin A(1), which pr
70 ore monensin, and bafilomycin A1, a specific vacuolar H+-ATPase inhibitor, each caused inhibition of
72 dose-dependent manner by treatment with the vacuolar H+-ATPase inhibitors concanamycin A and bafilom
77 nolocalization studies demonstrated that the vacuolar H+-ATPase is associated with this cupped cister
80 An intraluminal acidic pH, maintained by the vacuolar H+-ATPase, is one of the critical factors for s
82 reestablished across the tonoplast by either vacuolar H(+)-ATPase or vacuolar H(+)-pyrophosphatase.
86 Altogether, these findings indicate that the vacuolar (H+ ATPase plays a specific role in early sorti
88 environment, consistent with a role for the vacuolar (H+)-ATPase proton pump in copper assembly of l
90 al mechanisms of proton translocation by the vacuolar H(+)-ATPase require that a transmembrane acidic
91 rol of net acid excretion and for regulating vacuolar H+-ATPases residing on the plasma membrane inde
92 ron microscopy of prokaryotic and eukaryotic vacuolar H(+)-ATPases, respectively, clarifying their or
94 nd lytic vacuole/lysosome, and contained the vacuolar H(+)-ATPase subunit a3, alias TCIRG1, a known a
99 ence of clonogenic death after inhibition of vacuolar H+-ATPase suggest that formation of acidic orga
100 ng 4-acetyldiphyllin, a selective blocker of vacuolar H(+)-ATPase that increases the pH of intracellu
101 nships in the catalytic subunit of the yeast vacuolar H(+)-ATPase, the gene encoding this subunit (VM
102 ysis indicate that Tca1 colocalizes with the vacuolar H+-ATPase to the plasma membrane and to intrace
105 teoclasts, one of which is the d2 isoform of vacuolar (H(+)) ATPase (v-ATPase) V(0) domain (Atp6v0d2)
110 ecruitment of extrinsic V(1) subunits of the vacuolar (H(+))-ATPase (V-ATPase) to rat liver endosomes
111 N1 results in alterations in vacuolar pH and vacuolar (H(+))-ATPase (V-ATPase)-dependent H(+) transpo
115 hermore, we show that Rab5a colocalizes with vacuolar (H(+))-ATPases (V-ATPases) on transport vesicle
117 potent and highly specific inhibitors of the vacuolar (H(+))-ATPases (V-ATPases), typically inhibitin
125 in the presence of low concentrations of the vacuolar H(+) -ATPase (V-H(+) -ATPase) inhibitor bafilom
132 ne protein that serves as a component of the vacuolar H(+)-ATPase (V-ATPase) and also activates (pro)
133 lated cells (ICs) express the proton pumping vacuolar H(+)-ATPase (V-ATPase) and are extensively invo
134 An interaction between the B2 subunit of vacuolar H(+)-ATPase (V-ATPase) and microfilaments is re
135 in inhibits binding between the B-subunit of vacuolar H(+)-ATPase (V-ATPase) and microfilaments, and
138 that an activator subunit (Vma13p) of yeast vacuolar H(+)-ATPase (V-ATPase) binds to the cytoplasmic
139 investigate the function of subunit D in the vacuolar H(+)-ATPase (V-ATPase) complex, random and site
142 (vha14) encoding the 14-kDa F-subunit of the vacuolar H(+)-ATPase (V-ATPase) has been cloned via homo
143 dy capitalized on the mechanisms suppressing vacuolar H(+)-ATPase (V-ATPase) in pfk2Delta to gain new
159 rane protein and an accessory subunit of the vacuolar H(+)-ATPase (V-ATPase) that may also function w
160 ation-dependent interaction of the endosomal vacuolar H(+)-ATPase (V-ATPase) with cytohesin-2, a GDP/
162 Key to this restoration is activation of the vacuolar H(+)-ATPase (V-ATPase), a proton pump that acid
164 Moreover, ZnT2 directly interacted with vacuolar H(+)-ATPase (V-ATPase), and ZnT2 deletion impai
165 in is a potent and specific inhibitor of the vacuolar H(+)-ATPase (V-ATPase), binding to the V(0) mem
167 uins to deacetylate and subsequently inhibit vacuolar H(+)-ATPase (v-ATPase), which leads to AMPK act
175 A intercalated cells (A-ICs), which contain vacuolar H(+)-ATPase (V-type ATPase)-rich vesicles that
185 s required for full assembly and activity of vacuolar H(+)-ATPases (V-ATPases) containing the vacuola
187 unit C is a V(1) sector subunit found in all vacuolar H(+)-ATPases (V-ATPases) that may be part of th
188 We identify that genetic disruption of the Vacuolar H+ ATPase (V-ATPase), the key proton pump for e
192 age differentiation, the cellular content of vacuolar H+-ATPase (V-ATPase) increases more than 4-fold
197 It has been previously demonstrated that the vacuolar H+-ATPase (V-ATPase) of clathrin-coated vesicle
199 of the peripheral cytoplasmic domain of the vacuolar H+-ATPase (V-ATPase) were present in a SOS2-con
202 ew naturally occurring class of inhibitor of vacuolar H+-ATPases (V-ATPases) isolated from vacuolar m
205 salt, the activities of both the tonoplast (vacuolar) H(+)-ATPase (V-ATPase) and Na+/H+ antiporter i
206 related molecules, such as the d2 isoform of vacuolar H(+)-ATPase V0 domain and the dendritic cell-sp
207 e surrounding the algae abundantly expresses vacuolar H(+)-ATPase (VHA), which acidifies the symbioso
208 demonstrated that a 16-kDa subunit (16K) of vacuolar H(+)-ATPase via one of its transmembrane domain
212 on is due to a differential targeting of the vacuolar (H+) ATPase, which is not present on moving TeN
213 s is exacerbated in strains with a defective vacuolar H(+)-ATPase, which abolishes the ability of yea
214 itive regulatory E subunit (V-ATPase E) of a vacuolar H(+)-ATPase, which is responsible for acidifica